Literature DB >> 27638253

Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta.

Takako Tabata1, Matthew Petitt1, June Fang-Hoover1, Martin Zydek1, Lenore Pereira2.   

Abstract

Human cytomegalovirus (HCMV) is the leading viral cause of birth defects, including microcephaly, neurological deficits, hearing impairment, and vision loss. We previously reported that epithelial cells in amniotic membranes of placentas from newborns with intrauterine growth restriction and underlying congenital HCMV infection contain viral proteins in cytoplasmic vesicles. Herein, we immunostained amniotic membranes from 51 placentas from symptomatic and asymptomatic congenital infection with HCMV DNA in amniotic fluid and/or newborn saliva, intrauterine growth restriction, preterm deliveries, and controls. We consistently observed HCMV proteins in amniotic epithelial cells (AmEpCs) from infected placentas, sometimes with aberrant morphology. Primary AmEpCs isolated from mid-gestation placentas infected with pathogenic VR1814 proliferated and released infectious progeny for weeks, producing higher virus titers than late-gestation cells that varied by donor. In contrast to intact virion assembly compartments in differentiated retinal pigment epithelial cells, infected AmEpCs made dispersed multivesicular bodies. Primary AmEpCs and explants of amniochorionic membranes from mid-gestation placentas formed foci of infection, and interferon-β production was prolonged. Infected AmEpCs up-regulated anti-apoptotic proteins survivin and Bcl-xL by mechanisms dependent and independent of the activated STAT3. Amniotic membranes naturally expressed both survivin and Bcl-xL, indicating that fetal membranes could foster persistent viral infection. Our results suggest strengthening innate immune responses and reducing viral functions could suppress HCMV infection in the fetal compartment.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27638253      PMCID: PMC5222962          DOI: 10.1016/j.ajpath.2016.07.016

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  90 in total

1.  Stem cell characteristics of amniotic epithelial cells.

Authors:  Toshio Miki; Thomas Lehmann; Hongbo Cai; Donna B Stolz; Stephen C Strom
Journal:  Stem Cells       Date:  2005-08-04       Impact factor: 6.277

2.  Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA.

Authors:  Geoffrey B Smith; Edward S Mocarski
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age.

Authors:  Gisela Enders; Anja Daiminger; Ursula Bäder; Simone Exler; Martin Enders
Journal:  J Clin Virol       Date:  2011-08-05       Impact factor: 3.168

4.  Spatial relationships between markers for secretory and endosomal machinery in human cytomegalovirus-infected cells versus those in uninfected cells.

Authors:  Subhendu Das; Philip E Pellett
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

5.  Three-dimensional structure of the human cytomegalovirus cytoplasmic virion assembly complex includes a reoriented secretory apparatus.

Authors:  Subhendu Das; Amit Vasanji; Philip E Pellett
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

6.  Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells.

Authors:  Laura K Juckem; Karl W Boehme; Adam L Feire; Teresa Compton
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

7.  Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication.

Authors:  Fu-Zhang Wang; Frank Weber; Carlo Croce; Chang-Gong Liu; Xudong Liao; Philip E Pellett
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

8.  Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population.

Authors:  Marisa M Mussi-Pinhata; Aparecida Y Yamamoto; Rosângela M Moura Brito; Myriam de Lima Isaac; Patricia F de Carvalho e Oliveira; Suresh Boppana; William J Britt
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

9.  HCMV spread and cell tropism are determined by distinct virus populations.

Authors:  Laura Scrivano; Christian Sinzger; Hans Nitschko; Ulrich H Koszinowski; Barbara Adler
Journal:  PLoS Pathog       Date:  2011-01-13       Impact factor: 6.823

10.  Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Authors:  Manav Korpal; Brian J Ell; Francesca M Buffa; Toni Ibrahim; Mario A Blanco; Toni Celià-Terrassa; Laura Mercatali; Zia Khan; Hani Goodarzi; Yuling Hua; Yong Wei; Guohong Hu; Benjamin A Garcia; Jiannis Ragoussis; Dino Amadori; Adrian L Harris; Yibin Kang
Journal:  Nat Med       Date:  2011-08-07       Impact factor: 53.440

View more
  13 in total

Review 1.  Zika virus infection of first-trimester human placentas: utility of an explant model of replication to evaluate correlates of immune protection ex vivo.

Authors:  Matthew Petitt; Takako Tabata; Henry Puerta-Guardo; Eva Harris; Lenore Pereira
Journal:  Curr Opin Virol       Date:  2017-12       Impact factor: 7.090

2.  Viral infection dampens human fetal membrane type I interferon responses triggered by bacterial LPS.

Authors:  Julie A Potter; Mancy Tong; Paulomi Aldo; Ja Young Kwon; Mary Pitruzzello; Gil Mor; Vikki M Abrahams
Journal:  J Reprod Immunol       Date:  2020-04-08       Impact factor: 4.054

3.  Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Gen Virol       Date:  2020-02-18       Impact factor: 3.891

4.  Zika Virus Replicates in Proliferating Cells in Explants From First-Trimester Human Placentas, Potential Sites for Dissemination of Infection.

Authors:  Takako Tabata; Matthew Petitt; Henry Puerta-Guardo; Daniela Michlmayr; Eva Harris; Lenore Pereira
Journal:  J Infect Dis       Date:  2018-03-28       Impact factor: 5.226

5.  Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.

Authors:  Cody S Nelson; Diana Vera Cruz; Dollnovan Tran; Kristy M Bialas; Lisa Stamper; Huali Wu; Margaret Gilbert; Robert Blair; Xavier Alvarez; Hannah Itell; Meng Chen; Ashlesha Deshpande; Flavia Chiuppesi; Felix Wussow; Don J Diamond; Nathan Vandergrift; Mark R Walter; Peter A Barry; Michael Cohen-Wolkowiez; Katia Koelle; Amitinder Kaur; Sallie R Permar
Journal:  JCI Insight       Date:  2017-07-06

Review 6.  Trophoblastic extracellular vesicles and viruses: Friends or foes?

Authors:  Yingshi Ouyang; Jean-Francois Mouillet; Alexander Sorkin; Yoel Sadovsky
Journal:  Am J Reprod Immunol       Date:  2020-09-27       Impact factor: 3.886

Review 7.  Cytomegalovirus in pregnancy and the neonate.

Authors:  Vincent C Emery; Tiziana Lazzarotto
Journal:  F1000Res       Date:  2017-02-14

8.  Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas.

Authors:  Takako Tabata; Matthew Petitt; June Fang-Hoover; Daniel C Freed; Fengsheng Li; Zhiqiang An; Dai Wang; Tong-Ming Fu; Lenore Pereira
Journal:  Vaccines (Basel)       Date:  2019-09-29

9.  Infection of Placental Extravillous Cytotrophoblasts with Human Cytomegalovirus Causes a Treg/Th17 Imbalance at the Maternal-Fetal Interface.

Authors:  Yuan Qiao; Helena Kolibaba; Yukiko Mori; Tao Liu; Huijun Chen; Juanjuan Guo; Dan Xu; Yuanzhen Zhang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

10.  The Placental Response to Guinea Pig Cytomegalovirus Depends Upon the Timing of Maternal Infection.

Authors:  Zachary W Berkebile; Dira S Putri; Juan E Abrahante; Davis M Seelig; Mark R Schleiss; Craig J Bierle
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.